COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Early Phase Evaluation of ABC294640 in Patients With Refractory/Relapsed Diffuse Large B-cell Lymphoma or Kaposi Sarcoma (ABC-102)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02229981
Recruitment Status : Withdrawn (Study was discontinued due to lack of recruitment.)
First Posted : September 3, 2014
Last Update Posted : December 7, 2017
Louisiana State University Health Sciences Center in New Orleans
Apogee Biotechnology Corporation
Information provided by (Responsible Party):
RedHill Biopharma Limited